Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 12791

Winter Park, FL 32789

Study Summary:

A phase iii, randomized, double-blind, placebo-controlled study evaluating the efficacy, safety, and tolerability of two fixed dose combinations of aclidinium bromide/formoterol fumarate compared with aclidinium bromide, formoterol fumarate and placebo for 24-weeks treatment in patients with moderate to severe, stable chronic obstructive pulmonary disease (copd).

Qualified Participants Must:

• Be at least 40 years of age
• Be a current or former cigarette smokers with a cigarette smoking history
• Have a diagnosis of stable moderate to severe COPD.

Qualified Participants May Receive:

All study related medication and care at no cost. Eligible participants will be compensated for time and travel.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.